The DOI matches its OpenAlex record; 9 of the 9 references it cites were found in a registry or an index.
Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.
Abstract
OBJECTIVE: The aim of the present study was to investigate the prevalence and treatment of affective and anxiety disorders in adults in Australia and compare these with the dispensed prescriptions of drugs used to treat these disorders. METHODS: Analysis was done of the 2007 National Survey of Mental Health and Wellbeing regarding 12 month prevalence and treatment for affective and anxiety disorders and Pharmaceutical Benefits Scheme prescribing data for antidepressants for 2002-2007. The main outcome measures were prevalence and treatment (rates per 1000 population) and antidepressant utilization (defined daily dose 1000 population(-1) day-1) by gender and age (5 and 10 year age groups). RESULTS: The prevalence and treatment of affective and anxiety disorder are highest in those aged <50, after which it declines rapidly. Rates for both are higher in women than men. Overall antidepressant use increased 41% over the study period (selective serotonin re-uptake inhibitors 44%, venlafaxine 75%). Sertraline held the majority of the market, followed by venlafaxine and citalopram. Utilization of antidepressants had a bimodal distribution with peaks in those aged in their late 50s and early 90s. The peak use of antidepressants was in those aged 90-94 years. CONCLUSION: There is poor alignment between the prevalence and self-reported treatment of affective and anxiety disorders in the community and the prescribing of medications for these disorders. It appears that older Australians are receiving antidepressant medications for reasons other than the treatment of conditions for which these drugs have marketing approval or for depressive and anxiety symptoms that do not reach the threshold for a diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
2007 National Survey of Mental Health and Wellbeing: Methods and Key Findings
Slade, T., Johnston, A., Oakley Browne, M. A., Andrews, G., & Whiteford, H. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902970882 · Cited by 832
Self-citationBurgess, P. M., Pirkis, J. E., Slade, T. N., Johnston, A. K., Meadows, G. N., & Gunn, J. M. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902970858 · Cited by 318 · cited 6×
“A full description of the methodology of the NSMHWB is reported elsewhere [18].”
BackgroundInfluentialSelf-citationJorm, A. F., Jorm, A. F., Christensen, H., Griffiths, K. M., Jorm, A. F., Christensen, H., & Griffiths, K. M. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01561.x · Cited by 287
Jorm, A. F., Christensen, H., & Griffiths, K. M. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01738.x · Cited by 274
Parslow, R. A., & Jorm, A. F. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/000486700276 · Cited by 253
Begg, S. J., Vos, T., Barker, B., Stanley, L., & Lopez, A. D. (2008) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01503.x · Cited by 239
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“men [509,1304,1306,1307].”
Jorm, A. F., Patten, S. B., Brugha, T. S., & Mojtabai, R. (2017) · World Psychiatry · doi:10.1002/wps.20388 · Cited by 556
Alexander, R., Aragón, O. R., Bookwala, J., Cherbuin, N., Gatt, J. M., Kahrilas, I. J., Kästner, N., Lawrence, A., Lowe, L., Morrison, R. G., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.002 · Cited by 303
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217
“These trends are consistent with a recent Australian analysis suggesting a 41% increase in antidepressant prescribing between 2002 and 2007 (Hollingworth et al., 2010a).”
BackgroundResultInfluentialMackenzie, C. S., Karaoylas, E. C., & Starzyk, K. B. (2018) · Journal of Happiness Studies · doi:10.1007/s10902-017-9932-4 · Cited by 92
Metadata
- Authors
- Hollingworth, S., Burgess, P. M., & Whiteford, H.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2010-06-01
- Volume
- 44
- Issue
- 6
- Pages
- 513-9
- OpenAlex
- W1938123037
- Cited by
- 207
- References
- 9
- FWCI
- 60.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Affective and anxiety disorders: prevalence, treatment and antidepressant medication use. https://app.cochat.ai/papers/10.3109/00048670903555138
- The paper
- Hollingworth, S., Burgess, P. M., & Whiteford, H. (2010). Affective and anxiety disorders: prevalence, treatment and antidepressant medication use. PubMed. https://doi.org/10.3109/00048670903555138
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.